GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Price-to-Owner-Earnings

Universal Ibogaine (TSXV:IBO) Price-to-Owner-Earnings : (As of Jun. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Price-to-Owner-Earnings?

As of today (2024-06-25), Universal Ibogaine's share price is C$0.01. Universal Ibogaine does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Universal Ibogaine's Price-to-Owner-Earnings or its related term are showing as below:


TSXV:IBO's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.075
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-25), Universal Ibogaine's share price is C$0.01. Universal Ibogaine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-0.01. Therefore, Universal Ibogaine's PE Ratio for today is At Loss.

As of today (2024-06-25), Universal Ibogaine's share price is C$0.01. Universal Ibogaine's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.00. Therefore, Universal Ibogaine's PE Ratio without NRI for today is At Loss.


Universal Ibogaine Price-to-Owner-Earnings Historical Data

The historical data trend for Universal Ibogaine's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Price-to-Owner-Earnings Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Universal Ibogaine's Price-to-Owner-Earnings

For the Biotechnology subindustry, Universal Ibogaine's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Price-to-Owner-Earnings falls into.



Universal Ibogaine Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Universal Ibogaine's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.01/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Universal Ibogaine Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines